Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
SECURE, 2.0 times Increase in Ordinary Profit, Update Record High for Fourth Consecutive Term
4264 SECURE, INC. 【J-GAAP】
Earnings ReportSECURE, INC. <4264> [TSE Growth] announced its financial results after the market closed on February 13th (15:30). The consolidated ordinary profit for the fiscal year ended December 2025 increased by 2.0% from the previous period to 299 million yen. For the fiscal year ending December 2026, the consolidated ordinary profit is expected to surge 2.0 times the previous term, reaching 600 million yen, marking the fourth consecutive term of record-high profits. This will be the tenth consecutive term of revenue and the third consecutive term of profit growth.
In the most recent three-month period, from October to December (4Q), the consolidated ordinary profit surged 8.0 times that of the same period last year, reaching 112 million yen. The operating profit margin drastically improved from 1.0% in the same period last year to 6.4%.
Kabutan News
Actual Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Dec, 2023 | 5,191 | 187 | 175 | 168 | 35.7 | 0 | Feb 14, 2024 | J-GAAP |
| Dec, 2024 | 6,247 | 305 | 293 | 240 | 50.5 | 0 | Feb 14, 2025 | J-GAAP |
| Dec, 2025 | 6,840 | 326 | 299 | 187 | 34.3 | 0 | Feb 13, 2026 | J-GAAP |
| YoY | +9.5% | +6.9% | +2.0% | -22.1% | -32.1% |
Full Year Results vs. Previous Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Dec, 2025 Guidance | 6,840 | 326 | 299 | 187 | 34.3 | 0 | Feb 5, 2026 | J-GAAP |
| Dec, 2025 Results | 6,840 | 326 | 299 | 187 | 34.3 | 0 | Feb 13, 2026 | J-GAAP |
| Revision Rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Current Period Guidance
H1 Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jan - Jun, 2025 | 3,300 | 115 | 98 | 49 | 9.3 | 0 | Aug 13, 2025 | J-GAAP |
| Jan - Jun, 2026 Guidance | ー | ー | ー | ー | - | 0 | Feb 13, 2026 | J-GAAP |
| YoY | - | - | - | - | - |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Dec, 2024 | 6,247 | 305 | 293 | 240 | 50.5 | 0 | Feb 14, 2025 | J-GAAP |
| Dec, 2025 | 6,840 | 326 | 299 | 187 | 34.3 | 0 | Feb 13, 2026 | J-GAAP |
| Dec, 2026 Guidance | 8,206 | 620 | 600 | 410 | 72.7 | 0 | Feb 13, 2026 | J-GAAP |
| YoY | +20.0% | +90.2% | +100.7% | +119.3% | +112.0% |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Oct - Dec, 2024 | 1,525 | 16 | 14 | 27 | 5.7 | 1.0 | Feb 14, 2025 | J-GAAP |
| Jan - Mar, 2025 | 1,810 | 152 | 145 | 96 | 19.1 | 8.4 | May 13, 2025 | J-GAAP |
| Apr - Jun, 2025 | 1,490 | -37 | -47 | -47 | -9.0 | -2.5 | Aug 13, 2025 | J-GAAP |
| Jul - Sep, 2025 | 1,648 | 89 | 89 | 55 | 10.2 | 5.4 | Nov 13, 2025 | J-GAAP |
| Oct - Dec, 2025 | 1,892 | 122 | 112 | 83 | 15.2 | 6.4 | Feb 13, 2026 | J-GAAP |
| YoY | +24.1% | +662.5% | +700.0% | +207.4% | +168.0% |
Related Articles
NIPPON EXPRESS, 22 times Increase in Net Income for The Current Fiscal Year
M&A Research Institute, Oct-Dec (1Q) Net Income Decreases by 36%
Foodison, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 8%
Terminalcare Support Institute, 49% Increase in Ordinary Profit for The Current Fiscal Year
Startia Holdings, Ordinary Profit Forecast for the Fiscal Year Revised Upward by 6%, Raises Record High Profit Forecast, Dividend Revised Upward by 10 Yen
Kubota Pharma, Last Fiscal Year's Net Income Loss Narrows, Current period performance is undisclosed.
eGuarantee, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 5%, Oct-Dec Ordinary Profit Increases by 3%
Cuorips, Ordinary Profit Forecast for the Fiscal Year Loss Widened in Downward Revision
Nxera Pharma, Last Fiscal Year's Net Income Loss Widens, Current period performance is undisclosed.
MEEQ, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 63%, Oct-Dec Ordinary Profit Increases by 2.1 times